Rafael Bejar, MD, PhD, Director of the MDS Center of Excellence at the University of California, San Diego, suggests asking your doctor about the availability of
mutation testing and which
specific tests are available. Dr. Bejar also discusses how to ask about unrelated DNA variants, hereditary mutations associated with development of
myelodysplastic syndromes (
MDS), and mutations acquired during or after treatment that can indicate a better or worse MDS prognosis.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.